Since adenosine and its analogue 2-chloroadenosine prevent neutrophils from generating superoxide anion in response to chemoattractants, we sought to determine whether these agents could inhibit neutrophil-mediated hnjury of endothelial cells. The chemoattractant N-formyl-methionyl-leucyl-phenylalanine (FMLP, 0.1 ,uM) enhanced the adherence of neutrophils to endothelial cells twofold (18±2% vs. 39±3% adherence, P < 0.001) and caused substantial neutrophil-mediated injury to endothelial cells (2±2% vs. 39±4% cytotoxicity, P < 0.001). 2-Chloroadenosine (10 ,uM) not only inhibited the adherence of stimulated neutrophils by 60% (24±2% adherence, P < 0.001) but also diminished the cytotoxicity by 51% (20±4% cytotoxicity, P <0.002). Furthermore, depletion of endogenously released adenosine from the medium by adenosine deaminase-enhanced injury to endothelial cells by stimulated neutrophils (from 39±4% to 69±3% cytotoxicity, P < 0.001). Indeed, in the presence of adenosine deaminase, even unstimulated neutrophils injured endothelial cells (19±4% vs. 2±2% cytotoxicity, P < 0.001). These data indicate that engagement of adenosine receptors prevents both the adhesion of neutrophils and the injury they cause to endothelial cells. Adenosine inhibits injury provoked not only by cells that have been stimulated by chemoattractants but also by unstimulated cells. Based on this model of acute vascular damage we suggest that adenosine is not only a potent vasodilator, but plays the additional role of protecting vascular endothelium from damage by neutrophils.
Introduction
During inflammation activated neutrophils migrate in a directed fashion and become "sticky." They adhere to other neutrophils (cell-cell aggregation) and endothelial cells, release their lysosomal enzymes, and generate toxic oxygen metabolites (1) . A variety of agents can stimulate neutrophils to adhere to endothelial cells (2-4), and some of these agents can also provoke neutrophils to injure endothelial cells (5) (6) (7) (8) . Vascular endothelial cells are injured by toxic oxygen metabolites released by activated neutrophils (5) (6) (7) (8) , whereas endothelial cells are detached from their underlying matrix by lysosomal enzymes extruded by neutrophils (9) . We have recently observed that adenosine, a potent autacoid released from various tissues (10), inhibited anion and H202 release from stimulated neutrophils by engaging specific adenosine A2 receptors at their surface (11) (12) (13) . In contrast, adenosine did not affect either aggregation of neutrophils or release of lysosomal enzymes from neutrophils (11) . Others have confirmed these observations (14). Because adenosine is, therefore, a potential anti-inflammatory agent of endogenous origin, released by, for example, endothelial cells, we have determined that spontaneously released adenosine affects the ability of human neutrophils to kill endothelial cells. We have also studied the effects on neutrophilendothelial cell interactions of 2-chloroadenosine, a potent, poorly metabolized agonist at adenosine receptors. Data from these experiments show that both endogenously released adenosine and 2-chloroadenosine protect endothelial cells from injury by neutrophils. Louis, MO). N-Formyl-methionyl-leucyl-phenylalanine (FMLP)' was obtained from Vega Biochemicals (Tucson, AZ). Collagenase (type I) was purchased from Worthington Diagnostics (Freehold, NJ). 2'-Deoxycoformycin was a generous gift from Dr. John Douros (National Cancer Institute, Bethesda, MD). Tissue culture medium RPMI 1640 was obtained from Gibco Laboratories (Chagrin Falls, OH). Catalase was purchased from Calbiochem-Behring Corp. (La Jolla, CA). 5"Cr (sodium chromate) was obtained from New England Nuclear (Boston, MA).
Human umbilical vein endothelial cells. Human umbilical vein endothelial cells were obtained by collagenase treatment of fresh human umbilical cords and grown to confluence in Medium 199/human serum (20%) at 370C in a CO2 (5%) atmosphere (15) . Briefly, sterile umbilical cords were kept in buffered saline solution until use. A section ofumbilical vein (20 cm minimum) that was not damaged by clamps was cannulated, washed with medium, and then incubated with 10 ml of collagenase (0.1%) at 370C for 15 minutes. The endothelial cells were then collected, washed, and placed in a gelatin-coated 75-cm2 tissue culture flask in Medium 199/human serum (20%). The cells were then incubated for 2-3 d at 370C in a CO2 (5%) atmosphere, passed as necessary, and removed from the gelatin by collagenase treatment. 10 ml of collagenase (0.2%) was added to the flasks and the flasks were incubated at 370C for 15 min. The cells were collected, centrifuged, and washed before being layered onto 24-well tissue culture plates. Cells were grown to confluence at 370C in a CO2 (5%) atmosphere.
Labeling of endothelial cells with 5"Cr. For experiments involving 5'Cr release, the endothelial cells were incubated with 5'Cr (sodium chromate) in medium (5 MtCi/ml) for 2 h and washed twice before use (5) .
The endothelial cells took up 3-10% of the label (6,000-20,000 cpm).
Human neutrophils. Human neutrophils were isolated from whole blood after centrifugation through hypaque-ficoll gradients, sedimentation through dextran (6%, wt/vol), and hypotonic lysis ofred blood cells (16) . This procedure allows study of populations that are 98±2% neutrophils with few contaminating erythrocytes or platelets. In brief, fresh whole blood was layered over ficoll-hypaque and centrifuged (1,000 g, 45 min) at room temperature. The red cell pellet at the bottom of the gradient was collected and diluted with an equal volume of phosphate-buffered saline (PBS). A volume of dextran in normal saline equivalent to 20-30% of the volume of the diluted red cells was added and the red cells were permitted to sediment to -50% ofthe final volume. The supernate was collected and centrifuged at 700 g for 8 min. The pellet of neutrophils was resuspended in one volume of PBS and incubated with 3 vol of water (40 s) , and the incubation terminated by addition of 1 vol of 3.6% saline. The remaining neutrophils were then pelleted and washed twice in PBS and resuspended (50 X 106/ml) in medium supplemented with BSA (0.2%, wt/vol).
Labeling ofneutrophils with 5"Cr. For experiments to determine adherence neutrophils were labeled with 51Cr by a variation on the method of Gallin et al. (17) . In brief, neutrophils (24 X 106/ml) were incubated with 5"Cr (24 MtCi/ml) in RPMI 1640/0.2% BSA with constant gentle rocking for 1 h at 370C. The cells were then pelleted and washed three times in RPMI before suspension in RPMI 1640/0.2% BSA (25 X 106/ml).
Endothelial cell toxicity assays. Neutrophils were added to cultures of endothelial cells at a final concentration of 10 X 106/ml (10:1 neutrophils/endothelial cells) in Medium 199/BSA (0.2%). In some wells neutrophils were stimulated with FMLP (0.1 MM final concentration) in the presence or absence of 2-chloroadenosine (10 MM final concentration). The cultures were then incubated for 90 min at 37°C in a 5% CO2 atmosphere, gently washed twice, and examined with an inverted phasecontrast microscope. The adherent endothelial cells were counted using a technique that permits representative sampling of endothelial cell monolayers. Briefly, the undersurface of culture wells was marked using a template which allowed counting of similar sites in all wells. Endothelial cells were then counted in situ in two areas per well before and after incubation for 90 min with stimulated and unstimulated neutrophils in the presence or absence of 2-chloroadenosine. Cell counts obtained by this method were compared to cell counts obtained by hemocytometer and automated cell counter. To count cells by either hemocytometer or Coulter counter (Coulter Electronics, Inc., Hialeah, CA) the endothelial cells were harvested after incubation with collagenase (0.1%). The cells were then pelleted and resuspended in Medium 199, and an aliquot was counted in a hemocytometer or, after dilution with Isoton, counted in a Coulter counter. Cell counts obtained in situ correlated well with those obtained by hemocytometer (r = 0.99, P < 0.001, Fig. 1 ) and Coulter counter (r = 0.95, P < 0.001, Fig. 1 ). Endothelial cell toxicity varied with both the neutrophil donor and the endothelial cell line.
For those experiments in which release of5'Cr was used as an indicator of endothelial cell toxicity, the following procedure was used. Labeled endothelial cells were incubated with neutrophils and other agents for 90 min at 370C in a 5% CO2 atmosphere and the supernates were collected (5). Medium 199/BSA (0.2%) and RPMI 1640/BSA (0.2%) were used as the incubation media in these experiments, and are referred to as Medium 199 and RPMI, respectively. The medium used for each group of experiments is indicated. The adherent endothelial cells were collected after treatment with collagenase (0.2%) or, in some experiments, Triton X-100 (2%, vol/vol). Supernates and endothelial cells were counted in a gamma counter and percent release was calculated by use of the following formula: [cpm, ,,,/(cpm, tec + cpmte ".J)] x 100.
In some experiments supernates were spun at 1,000 rpm for 10 mi, the cell-free supernate was collected and counted, and the remaining cell pellet was counted separately. Percent cytotoxicity was calculated for each sample, in each experiment, by the following formula: % 5"Cr releasec,,p -% 5'Cr releaseontol-. Mean Examination ofsupernatesfor thepresence ofintact endothelial cells. Supernates of endothelial cell cultures were aspirated after incubation with neutrophils for 90 min at 370C. The remaining adherent cells were washed once with medium and the wash combined with the supernate. In some experiments supernates were stained directly with Giemsa stain and suspended cells counted in a hemocytometer. In other experiments an aliquot of supernates was spun onto a microscope slide in a cytocentrifuge at 300 rpm (Rainin Instrument Co., Boston, MA) and stained with Wright's stain, and the total number of endothelial cells present was counted. Endothelial cells were easily distinguished from neutrophils on the basis of their large size, uniform or vacuolated cytoplasm, and absence of cytoplasmic granules and large ovoid nuclei (Fig. 2) . The percentage of endothelial cells present was determined after counting 400 cells.
Preparation of enzymes for use in endothelial cell toxicity assays. Adenosine deaminase and xanthine oxidase were dialyzed against PBS for at least 6 h at 40C before dilution in medium. In some experiments adenosine deaminase (2.5 IU/ml) was incubated with deoxycoformycin (10 MtM) for 30 min at room temperature. The final concentration of preincubated adenosine dearninase was 0.25 IU/ml in these experiments.
Adherence ofneutrophils to endothelial cells. Adherence ofneutrophils to endothelial cells was assayed, essentially as described by Diener et al. (18) . Briefly, confluent monolayers of endothelial cells were grown in 16-mm diam tissue culture wells and were washed twice with medium.
5"Cr-labeled neutrophils were layered over endothelial cell monolayers in the presence or absence of 2-chloroadenosine (10 MM) and FMLP (0.1 MM) in a final volume of 0.5 ml. After incubation periods of 15-30 min at 370C in a 5% CO2 atmosphere, the supernatant was collected, the monolayers were washed once with medium, and the wash was added to the supernate. All wells were examined microscopically to determine whether loss of endothelial cells had occurred during incubation or washing. The remaining endothelial cells and adherent 51Cr-labeled neutrophils were lysed by the addition of 0.5 ml of NH40H (1.5 M) to each well followed by incubation overnight at room temperature (19) . The lysed endothelial cells and neutrophils were then collected and the radioactivity of both the supernates and lysed cells was determined by [cpmwd,/(cpm,,, + cpmwd,,)] X 100.
Analysis ofsupernates of endothelial cell cultures by reverse-phase high-pressure liquid chromatography. Endothelial cell cultures were washed twice and overlaid with fresh medium. Neutrophils and various agents were added and aliquots of the supernatants were collected after incubation for 0-30 min at 370C. These aliquots were kept frozen at -70'C until analysis could be performed. Proteins were precipitated with 2 N perchloric acid, the pH was readjusted to 7.0 with 2.2 N KOH, and the samples were centrifuged in an Eppendorf microfuge for 5 min at 40C (10,000 g) to eliminate the precipitated proteins. Adenosine concentrations were determined by reverse-phase high-pressure liquid chromatography as previously described (20) . The samples were applied to a C18 IABondapack column (Waters Associates, Inc., Milford, MA) and eluted with a 0-40% linear gradient (formed over 60 min) of 0.01 M ammonium phosphate (pH 5.5) and methanol, with a 1.5 ml/min flow rate. The adenosine peak was identified by retention time, the characteristic 250/260 UV absorbance ratio of adenosine, and disappearance of the peak after treatment with adenosine deaminase (0.25 IU/ml). Concentrations were determined by comparison of absorption at 260 nM to standards.
sphere. The supernatant medium was aspirated and the well was washed twice with medium. The wash was then combined with the aspirated supernate and an aliquot of the resulting suspension was spun onto a microscope slide in a cytocentrifuge at 300 rpm. The cells were then stained with Wright's stain.
Concentrations ofreagents. Unless otherwise indicated, the final concentrations of reagents used in these experiments were FMLP (0.1 M), 2-chloroadenosine (10 1sM), adenosine deaminase (0.25 IU/ml), and catalase (1,200 U/ml). The media used in these experiments were supplemented with 0.2% BSA.
Statistical analysis. The statistical significance of differences between the means of multiple sample populations was examined by use of oneway analysis ofvariance. Student's t test was used to compare differences between two sample populations. The values reported for 5 (Table II) . These results suggested that 2-chloroadenosine diminished adherence of neutrophils to endothelial cells by acting upon the neutrophils. Effect of2-chloroadenosine on endothelial cell toxicity mediated by activated neutrophils. Unstimulated neutrophils caused only minor loss of endothelial cells from their gelatin matrix after 90 min of incubation at 37°C (Fig. 3) . In contrast, neutrophils activated by FMLP caused marked loss of adherent endothelial cells from the matrix. 2-Chloroadenosine, at a concentration which maximally inhibits neutrophil function (10 ,M, 12), prevented this disappearance of endothelial cells (Fig. 3) . To quantitate these findings, the number of adherent endothelial cells in a defined area was counted in situ before and after incubation with neutrophils. Unstimulated neutrophils did not diminish the number of endothelial cells remaining adherent to gelatin coated plastic plates (104±7 vs. 107±5 cells/site, n = 6 sites, before and after incubation, respectively). In contrast, activated neutrophils (0.1 sM FMLP) significantly reduced the number of adherent endothelial cells (94±4 vs. 62±8 cells/site, n = 6 sites, P < 0.005). 2-Chloroadenosine (10 AM) prevented activated neutrophils from provoking loss of endothelial cells from their substratum (108±4 vs. 108±6 cells/site, n = 4 sites).
Endothelial cells may disappear from tissue culture wells because they are lysed or because they are detached from their matrix by activated neutrophils (5) (6) (7) (8) (9) . To distinguish between (Table IV) . Effect of2-chloroadenosine (10 W) on endothelial cell toxicity mediated by activated neutrophils as measured by 51Cr release. Unstimulated neutrophils did not injure endothelial cells (Table V) . Neutrophils exposed to FMLP, however, injured endothelial cells (P < 0.001 vs. unstimulated neutrophils, Table  V) . 2-Chloroadenosine partially reversed the effects of activated neutrophils on cultured endothelial cells (P < 0.002 vs. activated neutrophils).
Effect ofexogenous adenosine deaminase on endothelial cell toxicity due to activated neutrophils. We have previously reported that neutrophils release adenosine into their supernatant medium (I 1). Endothelial cells also release adenosine (21) . To determine whether endogenously released adenosine could affect the ability of activated neutrophils to injure endothelial cells, adenosine was removed by addition of adenosine deaminase. Adenosine deaminase dramatically enhanced endothelial cell injury caused by activated neutrophils (P < 0.001 vs. activated neutrophils alone, Table V ). After inactivation of the enzyme by preincubation with a specific inhibitor (deoxycoformycin), adenosine deaminase did not enhance neutrophil mediated injury (P < 0.001 vs. activated neutrophils plus adenosine deaminase, Table V) . 2-Chloroadenosine, which is poorly metabolized by adenosine deaminase, prevented injury to endothelial cells even in the presence ofadenosine deaminase (P < 0.001 vs. activated neutrophils plus adenosine deaminase, Table III. phils from harming endothelial cells (P < 0.005 vs. unstimulated neutrophils plus adenosine deaminase, Table V ). These results show that adenosine also prevented unstimulated neutrophils from injuring endothelial cells.
Adenosine concentrations in supernates of endothelial cell cultures. Both human neutrophils and umbilical vein endothelial cells can release adenosine into the surrounding medium (1 1,  21 ). The concentration of endogenously released adenosine reached in suspensions of neutrophils was previously shown to be sufficient to inhibit neutrophil function (1 1). To assess the concentration ofadenosine required for prevention ofendothelial cell injury, the concentration of adenosine was determined in supernates of endothelial cells incubated with neutrophils and activated neutrophils. Significant concentrations of adenosine were present in supernates from endothelial cells incubated with medium alone at the beginning and after 30 minutes of incubation (0.712±0.078 IM, mean±SEM, and 1.382±0.135 1AM, respectively, n = 3). Similar concentrations of adenosine were present in supernates of endothelial cells incubated in the presence of either unstimulated or activated neutrophils (1.064±0.072 MM and 1.301±0.120 MM, respectively, n = 4).
Source ofadenosine in supernatants. The concentration of adenosine present in supemates of endothelial cells before incubation was higher than expected. To determine the source of this adenosine the concentration of adenosine was determined in Medium 199/BSA (0.2%). Unexpectedly, Medium 199/BSA (0.2%) contained a high concentration of adenosine (0.51 1 MM, n = 2). Medium 199 is formulated with adenine and adenine nucleotides and the presence of adenosine is probably due to spontaneous breakdown of adenine nucleotides to adenosine in solution. Endothelial cells further metabolize adenine nucleotides to adenosine present after incubation (22) .
Because a high concentration of adenosine was present in Medium 199/BSA (0.2%), we reassessed the quantity of adenosine released into supernatants by endothelial cells and neutrophils in a medium that did not contain adenine or adenine nucleotides, RPMI 1640/BSA (0.2%). We also confirmed the effects of 2-chloroadenosine and adenosine deaminase on endothelial cell injury by neutrophils incubated in RPMI 1640/ BSA (0.2%).
Adenosine AM, respectively, n = 4, Fig. 4 ).
Effects of 2-chloroadenosine and adenosine deaminase on endothelial cell injury by activated neutrophils in RPMI 1640/ BSA (0.2%). As before, neutrophils exposed to FMLP injured endothelial cells (P < 0.001 vs. unstimulated neutrophils, Table   VI ). 2-Chloroadenosine (10 AM) dramatically diminished injury to endothelial cells by activated neutrophils (P < 0.001 vs. activated neutrophils, Table VI ). Adenosine deaminase enhanced endothelial cell injury by activated neutrophils (P < 0.004 vs. activated neutrophils, Table VI ). Despite the presence of exogenous adenosine deaminase, 2-chloroadenosine inhibited 5"Cr release from endothelial cells exposed to activated neutrophils (P < 0.001 vs. activated neutrophils plus adenosine deaminase, Table VI ). These data indicate that exogenous 2-chloroadenosine and endogenously released adenosine diminished injury to endothelial cells by activated neutrophils.
Effects of 2-chloroadenosine and adenosine deaminase on endothelial cell injury, in RPMI 1640/BSA (0.2%), by neutrophils Table III. which have not been exposed to a stimulus. In contrast to the findings ofexperiments performed in Medium 199/BSA (0.2%), unstimulated neutrophils incubated in RPMI 1640/BSA (0.2%) injured endothelial cells (P < 0.001 vs. endothelial cells alone, Table VI ). In the presence of adenosine deaminase unstimulated neutrophils were more injurious to endothelial cells (Table VI) , although the difference did not reach statistical significance. Again, even in the presence of adenosine deaminase, 2-chloroadenosine (10 ,M) decreased endothelial cell injury by neutrophils (P < 0.001 vs. unstimulated neutrophils plus adenosine deaminase; P < 0.03 vs. unstimulated neutrophils alone, Table VI) . Neither 2-chloroadenosine, adenosine deaminase, nor any of the other compounds added to the cultures caused increases in release of 5tCr from endothelial cells in the absence of neutrophils. In previous studies we have demonstrated that 2-chloroadenosine, adenosine and adenosine deaminase are neither scavengers nor generators of superoxide anion (11) . None of these agents significantly affected 51Cr release from endothelial cells incubated with the cell-free H202-generating system ofxanthine-xanthine oxidase (Table VII) . Discussion
These results indicate that 2-chloroadenosine, a poorly metabolized adenosine analogue, prevents adherence of stimulated neutrophils to endothelial cells and protects the endothelial cells from damage by neutrophils. Moreover, adenosine released into the medium from either endothelial cells or neutrophils prevents both stimulated and unstimulated neutrophils from damaging endothelial cells.
Several laboratories have reported that neutrophils release toxic oxygen metabolites, primarily H202, which injure endothelial cells (5) (6) (7) (8) . Neither adenosine nor 2-chloroadenosine prevents 51Cr release from endothelial cells caused by the cellfree H202-generating system ofxanthine-xanthine oxidase. Nor do either of these compounds act as scavengers of superoxide anion, the presumed precursor of H202 (1 1).. Thus, the ability ofadenosine and its analogue to prevent endothelial cell damage by neutrophils must be due to an effect ofthese compounds on neutrophils. Whether activated neutrophils can indeed injure endothelial cells or simply cause their detachment by release of proteolytic enzymes remains controversial (5) (6) (7) (8) (9) . In sharp contrast to our findings, Varani et al. (23) (25) . Although we cannot identify with certainty the cause(s) for these discrepancies, the conflicting findings reported from various laboratories most probably result from the disparate cultures and conditions used in these experiments. Depending on their source (human umbilical vein, human adipose tissue microvessels, bovine aorta, or bovine pulmonary artery) endothelial cells vary in their susceptibility to lysis by activated neutrophils (7). When serum is added to endothelial cell cultures exposed to activated neutrophils, scavengers of H202 may prevent damage (26) . Similarly, serum decreases the neutrophil-mediated detachment from substrates of endothelial cells because of serum antiproteases (9) . The failure ofFehr et al. (24) to find that FMLPstimulated neutrophils injured endothelial cells is probably due to their use of heparinized, heated plasma in which adherence proteins may be altered. Endothelial cells protect themselves from the deleterious effects of H202 via the glutathione redox cycle (27) . Since reduced glutathione present in tissue culture medium may raise intracellular glutathione concentrations (28) , the high concentrations of reduced glutathione in some tissue culture media (as high as 15 mg/liter in Waymouth's medium used by some investigators (9, 18, 27 ) and 1 mg/liter in RPMI 1640) may protect endothelial cells from oxidative damage due to stimulated neutrophils. Further, different tissue culture media contain different concentrations of vitamins, amino acids, and other nutrients (e.g., purine nucleotides and bases in Medium 199) which may also influence the ability of endothelial cells to withstand attack by activated neutrophils. Lastly, the method by which neutrophils are isolated from whole blood may enhance the ability of these cells to injure cultured endothelial cells (24, 29) . Thus, our demonstration that neutrophils stimulated by FMLP injured human umbilical vein endothelial cells differs from previous reports because of the source or preparation of the neutrophils and endothelial cells, the absence of serum or anticoagulated plasma, or use of different tissue culture media in our assay system.
We found that 2-chloroadenosine inhibited adherence of stimulated human neutrophils to human umbilical vein endothelial cells. In contrast, Pearson et al. (30) reported that adenosine enhanced adherence of unstimulated porcine neutrophils to cultured porcine endothelial cells. The cause of this discrepancy is, again, not absolutely identifiable but is most likely a result ofthe different species oforigin ofthe neutrophils studied. Similar species differences have been well documented for the effects ofadenosine on stimulated mast cell or basophil function (31) (32) (33) (34) . Our observation that 2-chloroadenosine inhibits stimulated neutrophil adherence to endothelial cells is important because neutrophil adherence is a critical first step for both endothelial cell injury (2, 5, 18, 35) and emigration of neutrophils from the vasculature (36) .
We, and subsequently others, have shown that adenosine and adenosine analogues inhibit generation of toxic oxygen metabolites by stimulated neutrophils via engagement ofadenosine A2 receptors on neutrophils (11) (12) (13) (14) . Once adherent, neutrophils may injure endothelial cells by generation oftoxic oxygen products (5) (6) (7) (8) . It is, therefore, probable that the protective effects of adenosine and 2-chloroadenosine are due to the interaction of adenosine and 2-chloroadenosine with the specific adenosine receptor on neutrophils. However, engagement of neutrophil adenosine receptors does not completely inhibit either release of toxic oxygen metabolites from activated neutrophils or adherence of neutrophils to endothelial cells (11) (12) (13) (14) . Thus, as we have shown here, 2-chloroadenosine at a concentration that maximally inhibits neutrophil function (10 ztM, [11] [12] [13] [14] does not completely inhibit endothelial cell injury by neutrophils.
Supernatants of endothelial cells incubated with and without neutrophils in Medium 199 contained significantly more adenosine than supernatants ofendothelial cells incubated in identical conditions in RPMI 1640. The disparity between the adenosine concentrations in supernatants incubated with these two media is due to the presence of adenine nucleotides in Medium 199 which must break down to adenosine during storage. Because of the presence of adenosine, Medium 199 is probably not suitable for use in experiments designed to determine the effects of adenosine or its analogues. Endothelial cells also actively metabolize adenine nucleotides to adenosine thus contributing to the adenosine present in the supernatants of endothelial cells incubated with Medium 199 (22) . In contrast, RPMI 1640 is not formulated with adenine nucleotides and contains no adenosine.
Depletion of adenosine from Medium 199 permitted unstimulated neutrophils to provoke a sixfold increase in endothelial cell injury whereas elimination of the smaller amounts of adenosine generated by the cells in RPMI 1640 allowed a smaller increment in endothelial cell injury by unstimulated neutrophils. Indeed, endothelial cells were injured by unstimulated neutrophils in the presence of the low concentrations of adenosine in RPMI 1640, and the increment in endothelial cell injury was significantly reversed by addition of2-chloroadenosine to the medium. It may be no accident that the concentration of adenosine in plasma is severalfold higher than that in RPMI 1640/BSA (20) ; indeed, plasma adenosine may moderate the effects of neutrophils on otherwise healthy tissues.
The uncontrolled or inappropriate activation of neutrophils has been implicated in the pathogenesis of a variety of human diseases. Persuasive evidence has been presented that activated neutrophils contribute to the adult respiratory distress syndrome by release of toxic oxygen metabolites that damage the pulmonary microvasculature (37, 38) . Activated neutrophils may also be responsible for damage to atherosclerotic vessels (39) , ischemic cardiac muscle (40) (41) (42) , as well as vascular damage in a variety of vasculitides (43, 44) . Recent studies suggest that adenosine is specifically released from endothelial cells in response to hydrogen peroxide (21) . Cardiac muscle also releases adenosine after ischemia or injury (45, 46). Endogenous adenosine, released by damaged cells and tissues, or pharmacologically active adenosine analogues may prevent vascular injury by neutrophils activated in the course of thrombosis or inflammation.
